Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03600883
Title A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreak 100)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amgen
Indications

Advanced Solid Tumor

Therapies

Sotorasib + unspecified PD-1 antibody

Sotorasib + unspecified PD-L1 antibody

Sotorasib

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.